Unknown

Dataset Information

Lysine specific demethylase 1 is a molecular driver and therapeutic target in sarcoma.


ABSTRACT: Sarcomas are a diverse group of tumors with numerous oncogenic drivers, and display varied clinical behaviors and prognoses. This complexity makes diagnosis and the development of new and effective treatments challenging. An incomplete understanding of both cell of origin and the biological drivers of sarcomas complicates efforts to develop clinically relevant model systems and find new molecular targets. Notably, the histone lysine specific demethylase 1 (LSD1) is overexpressed in a number of different sarcomas and is a potential therapeutic target in these malignancies. With the ability to modify histone marks, LSD1 is a key player in many protein complexes that epigenetically regulate gene expression. It is a largely context dependent enzyme, having vastly different and often opposing r

SUBMITTER: Dreher RD 

PROVIDER: S-EPMC9846348 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature